1
|
Faivre JC, Bibault JE, Leroy T, Agopiantz M, Salleron J, Wack M, Janoray G, Roché H, Culine S, Rivera S. Evaluation of the Theoretical Teaching of Postgraduate Radiation Oncology Medical Residents in France: a Cross-Sectional Study. JOURNAL OF CANCER EDUCATION : THE OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER EDUCATION 2018; 33:383-390. [PMID: 28138918 DOI: 10.1007/s13187-017-1170-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
This study's purpose was to have residents evaluate Radiation Oncology (RO) theoretical teaching practices in France. An anonymous electronically cross-functional survey on theoretical teaching practices in the RO residents was conducted by (i) collecting data from residents in the medical faculties in France, (ii) comparing the data across practices when possible and (iii) suggesting means of improvement. A total of 103 out of 140 RO residents responded to the survey (73.5% response rate). National, inter-university, university and internships courses do not exist in 0% (0), 16.5% (17), 53.4% (55) and 40.8% (42) of residents, respectively. Residents need additional training due to the shortage of specialised postgraduate degree training (49.5% (51)), CV enhancement to obtain a post-internship position (49.5% (51)) or as part of a career plan (47.6% (49)). The topics covered in teaching to be improved were the following: basic concept 61.2% (63), advanced concept 61.2 (63) and discussion of frequent clinical cases 50.5% (52). The topics not covered in teaching to be improved were the following: the development of career (66.0% (68)), medical English (56.3% (58)), the organisation of RO speciality (49.5% (51)) and the hospital management of RO department (38.8% (40)). This is the first national assessment of theoretical teaching of RO residents in France.
Collapse
Affiliation(s)
- Jean-Christophe Faivre
- French National Joint Union of Residents (ISNI), Paris, France.
- French Society of Young Radiation Oncologists (SFjRO), Paris, France.
- Institut de Cancérologie de Lorraine, Département Universitaire de Radiothérapie, 6, avenue de Bourgogne CS 30519, 54511, Vandoeuvre-lès-nancy cedex, France.
| | - Jean-Emmanuel Bibault
- French Society of Young Radiation Oncologists (SFjRO), Paris, France
- Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Thomas Leroy
- French Society of Young Radiation Oncologists (SFjRO), Paris, France
- Academic Radiation Oncology Department, Oscar Lambret Comprehensive Cancer Center, Lille, France
| | - Mikaël Agopiantz
- French National Joint Union of Residents (ISNI), Paris, France
- Department of Endocrinology and Medical Gynaecology, Nancy University Hospital, Vandœuvre-lès-Nancy, France
| | - Julia Salleron
- Biostatistics Department, Lorraine Institute of Cancerology - Alexis-Vautrin Comprehensive Cancer Center, Vandœuvre-lès-Nancy, France
| | - Maxime Wack
- Department of Biostatistics, Nancy University Hospital, Vandœuvre-lès-Nancy, France
| | - Guillaume Janoray
- French Society of Young Radiation Oncologists (SFjRO), Paris, France
- S. Kaplan Cancer Center, Radiation Oncology Department, University Hospital of Tours, Tours, France
| | - Henri Roché
- Institut Claudius Regaud, Institut Universitaire du Cancer Oncopole, Toulouse, France
| | - Stéphane Culine
- Medical Oncology Department, University Hospital of Paris (Saint-Louis Hospital), Paris, France
- French National College of Teachers of Cancer (CNEC), Paris, France
| | - Sofia Rivera
- Department of Radiation Oncology, Gustave Roussy, Villejuif, France
- European Society for Radiotherapy & Oncology (ESTRO) Education Committee, Brussels, Belgium
| |
Collapse
|
2
|
Bibault JE. [Stereotactic body radiation therapy for oligometastatic prostate cancer]. Bull Cancer 2017; 105:120-125. [PMID: 29191358 DOI: 10.1016/j.bulcan.2017.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Revised: 09/05/2017] [Accepted: 09/07/2017] [Indexed: 11/15/2022]
Abstract
INTRODUCTION The first line treatment of metastatic prostate cancer is medical or surgical androgen-deprivation. This treatment however has significant side effects that can affect the patients' quality of life. For oligometastatic patients, a new therapeutic approach, focusing on local treatment of metastases, is emerging. METHODS A systematic review of studies published on Stereotactic Body Radiation Therapy (SBRT) for oligometastatic prostate cancer was performed using results from search request on MEDLINE. RESULTS Treatment regimens vary from a single fraction of 20Gy (bone lesions) to ten fractions for a total dose of 64Gy (visceral metastases). Local control is 95.5 to 100% at 2 years with grade 1 and 2 toxicities around 10%, without any grade 3 side effects. These retrospective studies show the feasibility and very low toxicity of SBRT for this population of patients. The effect of SBRT on disease-free or global survival and quality of life has not been assessed. Several prospective trials (STOMP & ORIOLE) are underway. CONCLUSION Treating patients with up to five prostate cancer metastases is efficient and has a low toxicity. Prospective trials should identify which patients, if any, really benefit from this approach.
Collapse
Affiliation(s)
- Jean-Emmanuel Bibault
- Université Paris Descartes, Sorbonne Paris Cité, hôpital Européen Georges Pompidou, service d'oncologie radiothérapie, 20, rue Leblanc, 75015 Paris, France.
| |
Collapse
|